Evolving Treatment Strategies in High-Risk Neuroblastoma - Episode 2

Approaches to Diagnosing Neuroblastoma

,

Anurag Agrawal, MD, explains his approaches to diagnosing neuroblastoma, including urine markers, imaging, and bone marrow sampling, and emphasizes age and disease dissemination as major prognostic indicators alongside genetic predisposition and treatment response.

EP. 1: An Overview of Neuroblastoma
Now Viewing
EP. 2: Approaches to Diagnosing Neuroblastoma
EP. 3: Role of CURIE Scores in the Treatment and Management of Neuroblastoma
EP. 4: Current Treatment Paradigm for Newly Diagnosed Neuroblastoma
EP. 5: Differentiating Refractory and Relapsed Neuroblastoma
EP. 6: Updated Data From the LEAHRN Study in High-Risk Neuroblastoma
EP. 7: Available Treatment Options for Recurrent/Relapsed High-Risk Neuroblastoma (R/R HRNB)
EP. 8: Anti-GD2 Monoclonal Antibodies in Patients With R/R HRNB: Pivotal Clinical Trials
EP. 9: Strategies for Adverse Effect Management and Treatment Optimization With Anti-GD2 Monoclonal Antibodies in R/R
EP. 10: Future Perspectives in the Treatment of Neuroblastoma